Plexiform-like neurofibromas develop in the mouse by intraneural xenograft of an NF1 tumor-derived Schwann cell line

Journal of Neuroscience Research

Volumn 85, Issue 6, 2007, Pages 1347-1357

  Perrin, George Q ^a,b   Fishbein, Lauren ^a   Thomson, Susanne A ^a   Thomas, Stacey L ^c,d   Stephens, Karen ^e   Garbern, James Y ^f   DeVries, George H ^e,g   Yachnis, Anthony T ^a   Wallace, Margaret R ^a   Muir, David ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^d HINES VA HOSPITAL   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Angiogenesis; Neurofibroma; Neurofibromatosis; Plexiform; Xenograft

Indexed keywords

NEUROFIBROMIN; RAS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER TRANSPLANTATION; CARCINOGENESIS; CELL IMMORTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE DELETION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NEURINOMA; NEUROFIBROMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VASCULARIZATION; WESTERN BLOTTING; XENOGRAFT;

ADULT; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; FEMALE; HUMANS; LUNG NEOPLASMS; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; NERVE TISSUE PROTEINS; NEUROFIBROMATOSIS 1; NEUROFIBROMIN 1; RAS PROTEINS; SCHWANN CELLS; TRANSPLANTATION, HETEROLOGOUS;

EID: 34248187529     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21226     Document Type: Article

References (49)

1. Abernathy CR, Rasmussen SA, Stalker HJ, Zori R, Driscoll DJ, Williams CA, Kousseff BG, Wallace MR. 1997. NF1 mutation analysis using a combined heteroduplex/SSCP approach. Hum Mutat 9:548-554.
2. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. 1992. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 51:1229-1239.
3. Andersen LB, Ballester R, Marchuk DA, Chang E, Gutmann DH, Saulino AM, Camonis J, Wigler M, Collins FS. 1993. A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Mol Cell Biol 13:487-495.
4. Appenzeller O, Kornfeld M, Atkinson R, Snyder RD. 1986. Neurofibromatosis xenografts. Contribution to pathogenesis. J Neurol Sci 74:69-77.
5. Arbiser JL, Flynn E, Barnhill RL. 1998. Analysis of vascularity of human neurofibromas. J Am Acad Dermatol 38:950-954.
6. Blunt T, Gell D, Fox M, Taccioli GE, Lehmann AR, Jackson SP, Jeggo PA. 1996. Identification of a nonsense mutation in the carboxyl-terminal region of DNA-dependent protein kinase catalytic subunit in the seid mouse. Proc Natl Acad Sci U S A 93:10285-10290.
7. Brannan CI, Perkins AS, Vogel KS, Ratner N, Nordlund ML, Reid SW, Buchberg AM, Jenkins NA, Parada LF andCopeland NG. 1994. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev Rev 8:1019-1029.
8. Chanoki M, Ishii M, Fukai K, Kobayashi H, Hamada T, Muragaki Y, Ooshima A. 1991. Immunohistochemical localization of type I, III, IV, V, and VI collagens and laminin in neurofibroma and neurofibrosarcoma. Am J Dermatopathol 13:365-373.
9. Cichowski K, Shih TS, Schmitt E, Santiago S, Reilly K, McLaughlin ME, Bronson RT, Jacks T. 1999. Mouse models of tumor development in neurofibromatosis type 1. Science 286:2172-2176.
10. Colman SD, Williams CA, Wallace MR. 1995. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nat Genet 11:90-92.
11. De Raedt T, Brems H, Wolkenstein P, Vidaud D, Pilotti S, Perrone F, Mautner V, Frahm S, Sciot R, Legius E. 2003. Elevated risk for MPNST in NF1 microdeletion patients. Am J Hum Genet 72:1288-1292.
12. Dorschner MO, Sybert VP, Weaver M, Pletcher BA, Stephens K. 2000. NF1 microdeletion breakpoints are clustered at flanking repetitive sequences. Hum Mol Genet 9:35-46.
13. Dorshkind K, Keller GM, Phillips RA, Miller RG, Bosma GC, O'Toole M, Bosma MJ. 1984. Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease. J Immunol 132:1804-1808.
14. Enerback L, Miller HRP, Mayrhofer G. 1986. Methods for the identification and characterization of mast cells by light microscopy. In: Befus AD, Bienenstock J, Denburg JA, editors. Mast cell differentiation and heterogeneity. New York, NY: Raven Press. p 405-417.
15. Engvall E, Davis GE, Dickerson K, Ruoslahti E, Varon S andManthorpe M. 1986. Mapping of domains in human laminin using monoclonal antibodies: localization of the neurite-promoting site. J Cell Biol 103:2457-2465.
16. Folkman J. 2003. Angiogenesis and apoptosis. Semin Cancer Biol 13:159-167.
17. Graham JB, Neubauer D, Xue QS, Muir D. 2007. Chondroitinase applied to peripheral nerve repair averts retrograde axonal regeneration. Exp Neurol Jan; 203:185-195.
18. Gutmann DH, Wood DL, Collins FS. 1991. Identification of the neurofibromatosis type 1 gene product. Proc Natl Acad Sci USA 88:9658-9662.
19. Gutmann DH, Aynsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Viskochil D. 1997. The diagnostic evaluation and multi-disciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:51-57.
20. Gutmann DH, Giovannini M. 2002. Mouse models of Neurofibromatosis 1 and 2. Neoplasia 4:279-290.
21. Hirose T, Sano T, Hizawa K. 1986. Ultrastructural localization of S-100 protein in neurofibroma. Acta Neuropathol 69:103-110.
22. Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA. 1994. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet 7:353-361.
23. Krone W, Mao R, Muhleck OS, Kling H, Fink T. 1986. Cell culture studies on neurofibromatosis (von Recklinghausen). Characterization of cells growing from neurofibromas. Ann NY Acad Sci 486:354-370.
24. Lee JK, Sobel RA, Chiocca EA, Kim TS, Martuza RL. 1992. Growth of human acoustic neuromas, neurofibromas and schwannomas in the sub renal capsule and sciatic nerve of the nude mouse. J Neurooncol 14:101-112.
25. Lee ST, McGlennen RC, Litz CE. 1994. Clonal determination by the fragile X (FMR1) and phosphoglycerate kinase (PGK) genes in hematological malignancies. Cancer Res 54:5212-5216.
26. Leivo I, Engvall E, Laurila P, Miettinen M. 1989. Distribution of myrosin, a laminin-related tissue-specific basement membrane protein, in human Schwann cell neoplasms. Lab Invest 61:426-432.
27. Li Y, Rao PK, Wen R, Song Y, Muir D, Wallace P, Van Horne SJ, Tennekoon GI, Kadesch T. 2004. Notch and Schwann cell transformation. Oncogene 23:1146-1152.
28. Lopez-Correa C, Dorschner M, Brems H, Lazaro C, Clementi M, Upadhyaya M, Dooijes D, Moog U, Kehrer-Sawatzki H, Rutkowski JL, Fryns JP, Marynen P, Stephens K, Legius E. 2001. Recombination hotspot in NF1 microdeletion patients. Hum Mol Genet 10:1387-1392.
29. Lozupone F, Luciani F, Venditti M, Rivoltini L, Pupa S, Parmiani G, Belardelli F, Fais S. 2000. Murine granulocytes control human tumor growth in SCID mice. Int J Cancer 87:569-573.
30. Mertens F, Dal Cin P, De Wever I, Fletcher CD, Mandahl N, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, van Den Berghe H, Vanni R, Willen H. 2000. Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group. J Pathol 190:31-38.
31. Mirsky R, Jessen KR. 1999. The neurobiology of Schwann cells. Brain Pathol 9:293-311.
32. Muir D, Neubauer D, Lim IT, Yachnis AT, Wallace MR. 2001. Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells. Am J Pathol 158:501-513.
33. Obremski VJ, Johnson MI, Bunge MB. 1993. Fibroblasts are required for Schwann cell basal lamina deposition and ensheathment of unmyelinated sympathetic neurites in culture. J Neurocytol 22:102-117.
34. Perrin GQ, Fishbien L, Thompson S, Wallace M, Hwang MS, Mareci T, Yachnis AT, Muir D. 2006. Malignant peripheral nerve sheath tumors developed in the mouse by xenograft of an NF1 tumor-derived Schwann cell line. Oncogene. Submitted.
35. Rasmussen SA, Colman SD, Ho VT, Abernathy CR, Arn PH, Weiss L, Schwartz C, Saul RA, Wallace MR. 1998. Constitutional and mosaic large NF1 gene deletions in neurofibromatosis type 1. J Med Genet 35:468-471.
36. Ryan JJ, Klein KA, Neuberger TJ, Leftwich JA, Westin EH, Kauma S, Fletcher JA, DeVries GH, Huff TF. 1994. Role for the stem cell factor/KIT complex in Schwann cell neoplasia and mast cell proliferation associated with neurofibromatosis. J Neurosci Res 37:415-432.
37. Scheithauer BW, Woodruff JM, Erlandson RA. 1997. Tumors of the peripheral nervous system. In: Rosai J, Sobin LH, editors. Atlas of tumor pathology. Series 3. Fascicle 24. Washington, DC: Armed Forces Institute of Pathology. p 385-405.
38. Scott JE, Mowry RW. 1970. Alcian blue - a consumer's guide. J Histochem Cytochem 18:842.
39. Sheela S, Riccardi VM, Ratner N. 1990. Angiogenic and invasive properties of neurofibroma Schwann cells. J Cell Biol 111:645-653.
40. Singer-Sam J, LeBon JM, Tanguay RL, Riggs AD. 1990. A quantitative HpaII-PCR assay to measure methylation of DNA from a small number of cells. Nucleic Acids Res 18:687.
41. Stemmer-Rachamimov AO, Louis DN, Nielsen GP, Antonescu CR, Borowsky AD, Bronson RT, Burns DK, Cervera P, McLaughlin ME, Reifenberger G, Schmale MC, MacCollin M, Chao RC, Cichowski K, Kalamarides M, Messerli SM, McClatchey AI, Niwa-Kawakita M, Ratner N, Reilly KM, Zhu Y, Giovannini M. 2004. Comparative pathology of nerve sheath tumors in mouse models and humans. Cancer Res 64:3718-3724.
42. Suzuki Y, Suzuki H, Takamasa K, Yoshimoto T, Shibahara S. 1991. Brain tumors predominantly express the neurofibromatosis type 1 gene transcripts containing the 63 base insert in the region coding for GTPase activating protein-related domain. Biochem Biophys Res Commun 181:955-961.
43. Teinturier C, Danglot G, Slim R, Pruliere D, Launay JM, Bernhiem A. 1992. The neurofibromatosis 1 gene transcripts expressed in peripheral nerve and neurofibromas bear the additional exon located in the GAP domain. Biochem Biophys Res Commun 188:851-857.
44. Thomas SL, Deadwyler GD, Tang J, Stubbs EB, Muir D, Hiatt KK, Clapp DW, DeVries GH. 2006. Reconstitution of the NF1 GAP-related domain in NF1-deficient human Schwann cells. Biochem Biophys Res Comm 348:971-980.
45. Viskochil DH. 2003. It takes two to tango: mast cell and Schwann cell interactions in neurofibromas. J Clin Invest 112:1791-1793.
46. Wallace MR, Rasmussen SA, Lim IT, Gray BA, Zori RT, Muir D. 2000. Culture of cytogenetically abnormal Schwann cells from benign and malignant NF1 tumors. Genes Chromosomes Cancer 27:117-123.
47. Wu M, Wallace MR, Muir D. 2006. Nf1 haploinsufficiency augments angiogenesis. Oncogene 25:2297-2303.
48. Yang F-C, Ingram DA, Chen S, Hingtgen CM, Ratner N, Monk KR, Clegg T, White H, Mead L, Wenning MJ, Williams DA, Kapur R, Atkinson SJ, Clapp DW. 2003. Neurofibromin-deficient Schwann cells secrete potent migratory stimulus for Nf1 +/- mast cells. J Clin Invest 112:1851-1861.
49. Zhu Y, Ghosh P, Charnay P, Burns D, Parada LF. 2002. Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 296:920-922.